大昌華嘉 has signed an agreement to acquire Taiwanese companies 德怡科技 and 量子生物科技, enhancing its presence in the life sciences sector and aiming for strategic growth.

Target Company Overview

大昌華嘉 has signed an agreement to acquire two Taiwanese companies, 德怡科技 (TAQKEY Science) and 量子生物科技 (Quantum Biotech). This strategic move aligns with 大昌華嘉's objective to expand its presence in the life sciences sector and enhance its consumables business, solidifying its position as a leading provider of scientific solutions in Asia and globally.

Founded in 2002 and headquartered in Miaoli, Taiwan, 德怡科技 focuses on life sciences and the distribution of consumables. Together with 量子生物科技, they employ over 60 staff members and report annual net sales exceeding 13 million Swiss Francs. The companies boast robust profitability and maintain long-term, stable partnerships with well-known brands in the life sciences sector, operating seven business offices and three warehouses throughout Taiwan.

Industry Overview in Taiwan

The life sciences industry in Taiwan is rapidly expanding, driven by increasing investments in research and development, as well as favorable government policies aimed at b